Appili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections. By systematically identifying urgent infections with unmet needs, Appili’s goal is to strategically develop a pipeline of novel therapies to prevent deaths and improve lives. The Company is currently advancing a diverse range of anti-infectives, including a vaccine candidate to eliminate a serious biological weapon threat, a topical antiparasitic for the treatment of a disfiguring disease, and a novel easy to use, liquid oral formulation targeting parasitic and anaerobic infections. 

Biotechnology

Health Care

Therapeutics

Appili Therapeutics

Don Cilla

Leona Saunders

Art Baran

Carl Gelhaus

Gary Nabors

Kenneth Howling

The Research and Development team at Appili Therapeutics is responsible for advancing the company's pipeline of novel anti-infective therapies. The team focuses on nonclinical research, clinical trials, and new product development to address urgent, unmet medical needs in infectious diseases. Their work includes developing a vaccine candidate for a biological weapon threat, a topical antiparasitic for disfiguring diseases, and an innovative oral formulation for parasitic and anaerobic infections.

Research and Development

Leadership Team

Research and Development

About

Team members

Other teams at Appili Therapeutics

Leadership Team